Maura H Parker

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment
    Maura H Parker
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Stem Cells 30:2212-20. 2012
  2. ncbi MyoD-dependent regulation of NF-κB activity couples cell-cycle withdrawal to myogenic differentiation
    Maura H Parker
    Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada
    Skelet Muscle 2:6. 2012
  3. ncbi Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation
    Maura H Parker
    Program in Transplantation Biology, Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Mailstop D1 100, Seattle, WA, 98109 1024, USA
    Skelet Muscle 2:4. 2012
  4. ncbi Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs
    Maura H Parker
    Program in Transplantation Biology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Mol Ther 16:1340-6. 2008
  5. ncbi Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming
    Yi Cao
    Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Dev Cell 18:662-74. 2010

Collaborators

Detail Information

Publications5

  1. ncbi Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment
    Maura H Parker
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Stem Cells 30:2212-20. 2012
    ..A similar strategy of expanding human muscle-derived cells on Notch ligand might facilitate engraftment and muscle regeneration for patients affected with muscular dystrophy...
  2. ncbi MyoD-dependent regulation of NF-κB activity couples cell-cycle withdrawal to myogenic differentiation
    Maura H Parker
    Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada
    Skelet Muscle 2:6. 2012
    ..abstract:..
  3. ncbi Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation
    Maura H Parker
    Program in Transplantation Biology, Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Mailstop D1 100, Seattle, WA, 98109 1024, USA
    Skelet Muscle 2:4. 2012
    ..abstract:..
  4. ncbi Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs
    Maura H Parker
    Program in Transplantation Biology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Mol Ther 16:1340-6. 2008
    ..Taken together, these data indicate that immune tolerance to donor myoblasts provides an important platform from which to further improve myoblast transplantation, with the goal of restoring dystrophin expression to patients with DMD...
  5. ncbi Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming
    Yi Cao
    Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Dev Cell 18:662-74. 2010
    ..Therefore, in addition to regulating muscle gene expression, MyoD binds genome wide and has the ability to broadly alter the epigenome in myoblasts and myotubes...